REQUEST A DEMO
Total
USD $0.00
Search more companies

Novel Tissues Private Limited (India)

Main Activities: Fishing
Full name: Novel Tissues Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Novel Tissues Private Limited is an enterprise in India, with the main office in Mysore. The enterprise operates in the Fishing industry. It was first established on July 30, 2003. It currently has a total number of 3 (2023) employees. The latest financial highlights indicate a net sales revenue increase of 31.79% in 2023. A growth of 47.4% was recorded in its total assets. The net profit margin of Novel Tissues Private Limited decreased by 0.23% in 2023.

Legal Address
No.2, First Floor City Point13/7, Infantry Road
Mysore; Karnataka; Postal Code: 570018

Contact Details: Purchase the Novel Tissues Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Novel Tissues Private Limited report to view the information.
Registered Capital:
Purchase the Novel Tissues Private Limited report to view the information.
Financial Auditors:
Purchase the Novel Tissues Private Limited report to view the information.
Incorporation Date:
July 30, 2003
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
91.63%
Purchase this report to view the information.
0.37%
Company Performance
Financial values in the chart are available after Novel Tissues Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
31.79%
Total Operating Revenue
31.91%
Operating Profit
39.94%
EBITDA
45.18%
Net Profit/Loss for the Period
28.21%
Total Assets
47.4%
Total Equity
31.22%
Operating Profit Margin
0.74%
Net Profit Margin
-0.23%
Return on Equity (ROE)
-0.56%
Debt / Equity
23%
Quick Ratio
-1.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?